A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast Cancer

• Status: Recruiting
• Trial end date: 2024-04-01

Summary

A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment with Focus on Mechanisms of Resistance to Endocrine Treatment (fulvestrant/aromatase inhibitors) in Patients With Advanced Breast Cancer.

• Phase: Phase 2

Details

• Lead Sponsor: Lund University Hospital
• Collaborator: South Sweden Breast Cancer Group
• Treatments: Aromatase Inhibitors; Atorvastatin; Atorvastatin Calcium; Estradiol; Fulvestrant; Letrozole